- £32.97bn
- £40.46bn
- £11.03bn
Brief: Haleon Says On Track To Deliver 2025 Guidance, Remain Confident In Medium-Term Outlook
UK's Haleon posts third-quarter organic revenue marginally above estimates (updated)
UK's Haleon third-quarter organic revenue growth marginally beats estimates
Haleon 2025 Q3 Trading Statement
UK Stocks-Factors to watch on Oct-30
India's Dr Reddy's misses quarterly profit view on stiff competition for cancer drug generic
Director/PDMR Shareholding
Bank shares lift London's FTSE 100 to record, gold soars above $4,000 (updated)
Brief: Haleon PLC Selects Salesforce Agentforce Life Sciences Cloud For Customer Engagement
London's FTSE 100 hits fresh high as banks gain, gold tops $4,000
Director Declaration
Newscasts - GSK chief Walmsley to be replaced early by insider Luke Miels
British drugmaker GSK tops FTSE 100 as Walmsley to step down as chief
Director/PDMR Shareholding
Holding(s) in Company
Director/PDMR Shareholding
Brief: Wellnex Life Limited Receives Order From Haleon For UAE Market
UK's Haleon falls on Barclays' downgrade, PT cut
Director/PDMR Shareholding